Please Wait...

Ira Goodman

Translation skills

Main profile

Ira Goodman
Ira Goodman, MD
Key Opinion Leader

A board certified neurologist specializing in Alzheimer's disease, Parkinson's disease, dementia, and other neurodegenerative disorders, Dr. Goodman has worked on over 100 clinical trials. His investigations have covered all phases of clinical research and are highlighted by numerous groundbreaking trials in Alzheimer's disease. He is extensively published in the field of neurology, most particularly in the area of biomarkers in Alzheimer's disease.

In addition to his work as a Principal Investigator, Dr. Goodman serves as the Medical Director of the Compass Clinic, a private neurology practice within the Bioclinica Research Network.

He currently serves as an Associate Professor of Neurology at the University of Central Florida, College of Medicine and as an Associate Clinical Professor of Neurology at the University of Florida, College of Medicine.

Before joining the Bioclinica Research Network, Dr. Goodman led neurology at Orlando Regional Medical Center and founded the state-funded Memory Disorder Center of Central Florida, where he has served as director for the past 15 years.

Dr. Goodman has been named "Top Neurologist in Central Florida" for 14 consecutive years by Orlando Magazine, was named "Top Neurologist in the Country" by US News & World Report, and is sought after and quoted by The Wall Street Journal as a leading authority on Alzheimer's disease.

Dr. Goodman earned his medical degree at the Medical College of Pennsylvania.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SullyHIT: .@HIMSS writes new definition of interoperability - and seeks feedback https://t.co/p1fi4nqrsG @HealthITNews "This definition…
Bioclinica (2 days ago)
RT @DellEMCHealth: Top pharma use cases for the cloud https://t.co/mtPsdmfwXn via @HealthITNews #TransformHIT https://t.co/w14VstRwf0
Bioclinica (2 days ago)
RT @DDNewsOnline: Look into recent efforts to understand & fight #glioblastoma & #medulloblastoma Read our Spotlight on #Oncology “#Cancer…
Bioclinica (2 days ago)
Sponsors conducting clinical trials in #NAFLD or #NASH are invited to join us in an upcoming webinar exploring the… https://t.co/I19Bz8WLBa
Bioclinica (2 days ago)
RT @RAPSorg: Reorganization of @US_FDA’s Office of the Commissioner to Begin Soon | #Regulatory Focus https://t.co/9b3UshJUgD #FDA
Bioclinica (2 days ago)
RT @ACROhealth: More than 325 million people own wearable devices, making it more convenient than ever for researchers to incorporate them…
Bioclinica (2 days ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box